Related references
Note: Only part of the references are listed.Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education
Keith A. Johnson et al.
Alzheimers & Dementia (2013)
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
Agneta Nordberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia
Javier Arbizu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
A. Bruck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Amyloid-beta Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods
Susan M. Landau et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
PET Quantification of 18F-Florbetaben Binding to β-Amyloid Deposits in Human Brains
Georg A. Becker et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Biomarkers for Alzheimer's: the sequel of an original model
Giovanni B. Frisoni et al.
LANCET NEUROLOGY (2013)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
Clifford R. Jack et al.
LANCET NEUROLOGY (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches
Ann D. Cohen et al.
NEUROIMAGE (2013)
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Annapaola Prestia et al.
NEUROLOGY (2013)
Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers
Jennifer L. Shaffer et al.
RADIOLOGY (2013)
Brain Amyloid Imaging
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2013)
The use of PIB-PET as a dual pathological and functional biomarker in AD
Anton Forsberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study
Nicolas Villain et al.
BRAIN (2012)
Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
V. Camus et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease
Victor L. Villemagne et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
Nicolaas I. Bohnen et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Generalized population-based input function estimation given incomplete blood sampling in quantitative dynamic FDG PET studies
Yun Zhou et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Summary Metrics to Assess Alzheimer Disease Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison
Anna Caroli et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Translational studies with [11C] MK-3168, a PET tracer for fatty acid amide hydrolase (FAAH)
Aniket Joshi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study
Adam S. Fleisher et al.
LANCET NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Biomarker trajectories across stages of Alzheimer disease
Giovanni B. Frisoni
Nature Reviews Neurology (2012)
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease
Ahmadul Kadir et al.
NEUROBIOLOGY OF AGING (2012)
Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?
P. Edison et al.
NEUROIMAGE (2012)
Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant
Elizabeth C. Mormino et al.
NEUROIMAGE (2012)
Clinical Validation of a Grid-Based SPM Web Tool for the Automatic Assessment of [18F]FDG PET Brain Metabolic Abnormalities in Single Subjects (P03.106)
P. Della Rosa et al.
NEUROLOGY (2012)
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
G. Chetelat et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
Relative Equilibrium Plot Improves Graphical Analysis and Allows Bias Correction of Standardized Uptake Value Ratio in Quantitative 11C-PiB PET Studies
Yun Zhou et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
Abhinay D. Joshi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Biomarkers in Alzheimer's disease drug development
Jeffrey L. Cummings
Alzheimers & Dementia (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
PET/CT in diagnosis of dementia
Valentina Berti et al.
PET/CT APPLICATIONS IN NON-NEOPLASTIC CONDITIONS (2011)
PET/CT in diagnosis of movement disorders
Valentina Berti et al.
PET/CT APPLICATIONS IN NON-NEOPLASTIC CONDITIONS (2011)
Association Between In Vivo Fluorine 18-Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology
David A. Wolk et al.
ARCHIVES OF NEUROLOGY (2011)
Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
Adam S. Fleisher et al.
ARCHIVES OF NEUROLOGY (2011)
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls
Henryk Barthel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical practice guidelines
Jonathan Hsu et al.
IMPLEMENTATION SCIENCE (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Nuclear Medicine Diagnostic Techniques in the Era of Pathophysiology-Based CSF Biomarkers for Alzheimer's Disease
Markus Weih et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Early 11C-PIB Frames and 18F-FDG PET Measures Are Comparable: A Study Validated in a Cohort of AD and FTLD Patients
Ara H. Rostomian et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B
Philipp T. Meyer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Amyloid Imaging with 18F-Florbetaben in Alzheimer Disease and Other Dementias
Victor L. Villemagne et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'
Rudy J. Castellani et al.
JOURNAL OF PATHOLOGY (2011)
Clinical amyloid imaging in Alzheimer's disease
Karl Herholz et al.
LANCET NEUROLOGY (2011)
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
Henryk Barthel et al.
LANCET NEUROLOGY (2011)
Predictive markers for AD in a multi-modality framework: An analysis of MCI progression in the ADNI population
Chris Hinrichs et al.
NEUROIMAGE (2011)
Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET
Bedda L. Rosario et al.
NEUROIMAGE (2011)
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
G. D. Rabinovici et al.
NEUROLOGY (2011)
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
Jason Karlawish
NEUROLOGY (2011)
Amyloid PET imaging in patients with mild cognitive impairment A 2-year follow-up study
J. Koivunen et al.
NEUROLOGY (2011)
Positron Emission Tomography Radiopharmaceuticals for Imaging Brain Beta-Amyloid
Shankar Vallabhajosula
SEMINARS IN NUCLEAR MEDICINE (2011)
Brain Amyloid Imaging
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
William J. Jagust et al.
ALZHEIMERS & DEMENTIA (2010)
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
K. B. Walhovd et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Relationship between Atrophy and β-Amyloid Deposition in Alzheimer Disease
Gael Chetelat et al.
ANNALS OF NEUROLOGY (2010)
18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
Rik Vandenberghe et al.
ANNALS OF NEUROLOGY (2010)
Amyloid-plaque imaging in early and differential diagnosis of dementia
Alexander Drzezga
ANNALS OF NUCLEAR MEDICINE (2010)
High PIB Retention in Alzheimer's Disease is an Early Event with Complex Relationship with CSF Biomarkers and Functional Parameters
A. Forsberg et al.
CURRENT ALZHEIMER RESEARCH (2010)
Voxel-Based Analysis of Amyloid Positron Emission Tomography Probe [C-11]BF-227 Uptake in Mild Cognitive Impairment and Alzheimer's Disease
He Shao et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study
Silvia Morbelli et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls
D. P. Devanand et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2010)
Revising the definition of Alzheimer's disease: a new lexicon
Bruno Dubois et al.
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Typical Cerebral Metabolic Patterns in Neurodegenerative Brain Diseases
Laura K. Teune et al.
MOVEMENT DISORDERS (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
Comparing predictors of conversion and decline in mild cognitive impairment
S. M. Landau et al.
NEUROLOGY (2010)
Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies
J. L. Brozek et al.
ALLERGY (2009)
Fluorodeoxyglucose-Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis
Y. Yuan et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
Amyloid Imaging in Mild Cognitive Impairment Subtypes
David A. Wolk et al.
ANNALS OF NEUROLOGY (2009)
Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease
Clayton A. Wiley et al.
ARCHIVES OF NEUROLOGY (2009)
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
Timo Grimmer et al.
BIOLOGICAL PSYCHIATRY (2009)
Performance of FDG PET for Detection of Alzheimer's Disease in Two Independent Multicentre Samples (NEST-DD and ADNI)
C. Haense et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease
Lisa Mosconi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Comparison of 18F-FDG and PiB PET in Cognitive Impairment
Val J. Lowe et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease
Masaaki Waragai et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Imaging Amyloid in Parkinson's Disease Dementia and Dementia with Lewy Bodies with Positron Emission Tomography
David J. Brooks
MOVEMENT DISORDERS (2009)
Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility
Paul Edison et al.
NEUROIMAGE (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
Conversion of amyloid positive and negative MCI to AD over 3 years An 11C-PIB PET study
A. Okello et al.
NEUROLOGY (2009)
Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease
Ahmadul Kadir et al.
ANNALS OF NEUROLOGY (2008)
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B
Ville Leinonen et al.
ARCHIVES OF NEUROLOGY (2008)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias
Lisa Mosconi et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer:: proof of mechanism
Christopher C. Rowe et al.
LANCET NEUROLOGY (2008)
The ART of loss:: Aβ imaging in the evaluation of Alzheimer's disease and other dementias
Victor L. Villemagne et al.
MOLECULAR NEUROBIOLOGY (2008)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis
A. Lockhart et al.
BRAIN (2007)
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Norman L. Foster et al.
BRAIN (2007)
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
W. Jagust et al.
NEUROLOGY (2007)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease
Steven Ng et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
Ian McKeith et al.
LANCET NEUROLOGY (2007)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
[11]PIB in a nondemented population -: Potential antecedent marker of Alzheimer disease
M. A. Mintun et al.
NEUROLOGY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease
D Anchisi et al.
ARCHIVES OF NEUROLOGY (2005)
Fluent versus nonfluent primary progressive aphasia: A comparison of clinical and functional neuroimaging features
DG Clark et al.
BRAIN AND LANGUAGE (2005)
Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease - FDG-PET studies in MCI and AD
L Mosconi
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing
S Gilman et al.
EXPERIMENTAL NEUROLOGY (2005)
Validation of anatomical standardization of FDG PET images of normal brain: comparison of SPM and NEUROSTAT
K Hosaka et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
MCI conversion to dementia and the APOE genotype -: A prediction study with FDG-PET
L Mosconi et al.
NEUROLOGY (2004)
Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC
GB Frisoni et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia
E Salmon et al.
NEUROIMAGE (2003)
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
K Herholz et al.
NEUROIMAGE (2002)
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the nun study
KP Riley et al.
ANNALS OF NEUROLOGY (2002)
A lipophilic thioflavin-T derivative for positron emission tomography (PET) Imaging of amyloid in brain
CA Mathis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Current concepts in mild cognitive impairment
RC Petersen et al.
ARCHIVES OF NEUROLOGY (2001)
Positron emission tomography in evaluation of dementia - Regional brain metabolism and long-term outcome
DHS Silverman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET)
MJ de Leon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
S Minoshima et al.
ANNALS OF NEUROLOGY (2001)
Hippocampal formation glucose metabolism and volume losses in MCI and AD
S De Santi et al.
NEUROBIOLOGY OF AGING (2001)
Practice parameter: Diagnosis of dementia (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
DS Knopman et al.
NEUROLOGY (2001)
Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment
E Arnáiz et al.
NEUROREPORT (2001)
Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling
PJ Magistretti
BRAIN RESEARCH (2000)
Share Paper
